What the CABENUVA
clinical studies show

Jakub

Stays undetectable
with CABENUVA

Results may vary.

What the CABENUVA
clinical studies show

Jakub

Stays undetectable 
with CABENUVA

Results may vary.

CAN CABENUVA KEEP ME UNDETECTABLE? 

Once-a-month CABENUVA is proven to be as effective as daily HIV pills at keeping people undetectable.*†‡§

Checkmark icon

Once-a-month CABENUVA is proven to be as effective as daily HIV pills at keeping people undetectable.*†‡§

CABENUVA was tested in 2 clinical studies:

  • With more than 1,000 adults
  • Over a 48-week period

People were already undetectable and divided into 2 equal groups:

  • Those who switched to CABENUVA
  • Those who continued on their current daily pill regimen

The studies included a diverse range of people across age, race, and gender, including transgender individuals.

At Week 48:

  • 9 out of 10 people remained undetectable, whether they were on daily HIV pills or CABENUVA
  • Less than 2% of people did not remain undetectable (primary endpoint)

You’ll take about a month of once-daily starter pills before beginning CABENUVA. Stay under the care of your doctor during treatment.

Daily pill regimens tested contained dolutegravir and 2 nucleoside reverse transcriptase inhibitors (NRTIs).

Undetectable means the amount of HIV in the blood is below the level that can be measured by a lab test (less than 50 copies/mL).

Results may vary.

WHAT WERE THE SIDE EFFECTS?

The most common side effects reported in clinical studies were injection-site reactions.||

83%

of people in the clinical studies experienced injection-site reactions.

99%

of injection-site reactions were mild to moderate.

Aside from injection-site reactions, the most common side effects were:

Side effect Switched to
CABENUVA
Continued on
daily pill regimen
Fever 8% 0%
Tiredness 5% <1%
Headache 4% <1%
Muscle or
bone pains
3% <1%
Nausea 3% 1%
Sleep problems 2% <1%
Dizziness 2% <1%
Rash 2% 0%

4%

of people on CABENUVA stopped treatment due to any side effect.

Results may vary.
Injection-site reactions include pain, tenderness, hardened mass or lump, swelling, redness, itching, bruising, and warmth at the injection site.

These are not the only side effects of CABENUVA. For more information, see the Risks & Side Effects page. Always tell your doctor if you experience any side effect.

DID PEOPLE PREFER ONCE-MONTHLY CABENUVA OVER DAILY PILLS?

9 out of 10 people who switched to CABENUVA preferred once-a-month injections over their previous daily pill regimen†§¶

Preference 9 out of 10

9 out of 10 people who switched to CABENUVA preferred once-a-month injections over their previous daily pill regimen†§¶

In a survey conducted during the clinical studies, people were asked how they felt about their treatment, including which one they preferred. The results are their opinions and don’t imply clinical effectiveness.

Could the same be true for you? Find out how to have the CABENUVA conversation with your doctor.

88% of people said they preferred CABENUVA, 2% preferred previous daily pill regimen, and 10% did not respond to the survey question.

After my injection I was sore, but the next day I didn’t have to take my HIV pill.

Photograph of Mark

After my injection I was sore, but the next day I didn’t have to take my HIV pill.

Mark

Stays undetectable
with CABENUVA

Results may vary.

COULD SWITCHING TO
CABENUVA BE RIGHT FOR ME?

ASK YOUR DOCTOR TO FIND OUT

WANT MORE
INFORMATION?

LEARN ABOUT CABENUVA

Learn About
Other People’s
Experiences
ON CABENUVA

See Stories

CBRWCNT190008